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Abstract Wnt signaling is a key pathway that helps
organize development of the nervous system. It influences
cell proliferation, cell fate, and cell migration in the
developing nervous system, as well as axon guidance,
dendrite development, and synapse formation. Given this
wide range of roles, dysregulation of Wnt signaling could
have any number of deleterious effects on neural develop-
ment and thereby contribute in many different ways to the
pathogenesis of neurodevelopmental disorders. Some major
psychiatric disorders, including schizophrenia, bipolar
disorder, and autism spectrum disorders, are coming to be
understood as subtle dysregulations of nervous system
development, particularly of synapse formation and main-
tenance. This review will therefore touch on the importance
of Wnt signaling to neurodevelopment generally, while
focusing on accumulating evidence for a synaptic role of
Wnt signaling. These observations will be discussed in the
context of current understanding of the neurodevelopmental
bases of major psychiatric diseases, spotlighting schizo-
phrenia, bipolar disorder, and autism spectrum disorder. In
short, this review will focus on the potential role of synapse
formation and maintenance in major psychiatric disorders
and summarize evidence that defective Wnt signaling could
contribute to their pathogenesis via effects on these late
neural differentiation processes.
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Wnt signaling pathways
The Wnt family of signaling molecules are small secreted
glycoproteins best known for their role as critical regulators
of cell fate specification, cell proliferation, and cell
migration during development. There are 19 Wnt ligands
made from different genetic loci in humans and a similar
number in other mammals. Wnt signaling is mediated by
Wnt ligands binding to the Frizzled (Fzd) family of
receptors, the co-receptors low density lipoprotein
receptor-related protein 5 and 6 (LRP5/6), or alternatively
the Ryk and Ror receptor tyrosine kinases (Komiya and
Habas 2008). Wnts can initiate several signaling pathways
through activation of these different receptor types and
complexes (Fig. 1).
The so-called canonical Wnt/β-catenin signaling pathway
involves Wnt binding to Fzd and LRP5/6, followed by Fzd
binding to the scaffold protein Disheveled (dsh in fly, Dvl in
vertebrates). Dvl then binds and destabilizes the β-catenin
destruction complex, a group of proteins including glycogen
synthase kinase 3 (GSK3) and the scaffold proteins axin
and adenomatous polyposis coli (APC), among others.
The constitutively functioning destruction complex binds
β-catenin and targets it for poly-ubiquitination and
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DOI 10.1007/s11689-011-9083-6degradation in the proteosome. When the β-catenin
destruction complex is destabilized by Wnt activation
and Dvl binding, β-catenin accumulates in the cytoplasm
and in the nucleus, where it binds members of the
lymphoid enhancer-binding factor/T cell-specific tran-
scription factor (LEF/TCF) transcription factor family,
preventing their repression of gene transcription and
functioning as a transcription co-activator (Komiya and
Habas 2008; Gao and Chen 2010). The Wnt/β-catenin
signaling pathway has been intensely studied as a key
regulator of cell proliferation and cell fate during develop-
ment, including neural development (Machon et al. 2007;
Zhou et al. 2004, 2006; Galercan et al. 2000).
There is also “non-canonical” β-catenin-independent
signal transduction that occurs downstream of Wnts
binding to Fzds and other receptors. In the Wnt/Ca
++
signaling pathway, Wnt signaling through Fzd and Dvl
initiates release of intracellular stores of calcium, driving
calcium-dependent signaling in the cell through such targets
as atypical protein kinase C and calcium/calmodulin-
dependent protein kinase II (Kohn and Moon 2005). Wnt
signaling also contributes to the planar cell polarity (PCP)
signaling pathway. Like previously mentioned pathways,
Wnt/PCP signaling depends on Fzd and Dvl, but with Rho
GTPases and the Jun N-terminal kinase (JNK) as downstream
targets rather than the β-catenin destruction complex (Gao
and Chen 2010; Kohn and Moon 2005; Habas et al. 2003;
Habas and He 2006). PCP signaling, like Wnt/β-catenin
signaling, is a key pathway in organizing the developing
organism, and many genes in both the Wnt/β-catenin and
PCP signaling pathways were first discovered in Drosophila
because mutations of these genes led to disorganization of
body structures such as the eye and wing hairs (Vladar et al.
2009; Simons and Mlodzik 2008). PCP signaling in
vertebrates is associated with organization of cilia in the
inner ear, hair growth, and, most critically, with elongation
of the body axis and formation of the neural tube through the
process of convergent extension (Simons and Mlodzik 2008;
Mlodzik 2002).
Wnt ligands are often subgrouped based on the down-
stream pathway they activate in vivo, which is presumably
a function of their affinity for certain receptor complexes
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Fig. 1 Wnts signal through a “canonical” pathway involving β-
catenin mediated transcriptional regulation (at left) and through “non-
canonical” pathways involving calcium and Rac/JNK-mediated
signaling (at right). In the absence of Wnt, the β-catenin destruction
complex, whose core members are the scaffold proteins axin and
adenomatous polyposis coli (APC) and the protein kinase glycogen
synthase kinase 3β (GSK3β), binds and phosphorylates β-catenin.
Phospho-β-catenin is then ubiquitinated and destroyed in the
proteosome. Wnt binding to Fzd and LRP5/6 activates Disheveled,
which breaks up the β-catenin destruction complex. This leads to
accumulation of β-catenin in the cytosol and translocation of β-
catenin into the nucleus, where it forms complexes with LEF/TCF
transcription factors to promote transcription of selected gene targets.
Wnt binding to Fzd can also trigger the Wnt/calcium signaling
pathway involving calcium-dependent activation of CamK and PKC,
or to the Wnt/PCP signaling pathway which leads to regulation of
small GTPases and JNK. Wnt signaling is inhibited extracellularly by
Dkk proteins, which specifically bind to LRP5/6 and thereby
antagonize only Wnt/β-catenin signaling, or by secreted Frizzled-
related proteins (SFRPs) and Wnt inhibitory factor (WIF), which bind
Wnts extracellularly to antagonize all Wnt-activated signaling path-
ways
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tissues. For example, Wnt1, Wnt2, Wnt3a, Wnt7a, and
Wnt7b are typically considered activators of the β-catenin
pathway, whereas Wnt4 and Wnt5a are typically considered
activators of β-catenin-independent forms of signaling
(Moon et al. 1997).
Wnts and nervous system development
In vertebrates, Wnts have well-established roles in brain
development, dating back to the discovery that knockout of
the Wnt1 gene in mice produces dramatic hypotrophy of the
cerebellum and midbrain (Thomas and Capecchi 1990).
This has since been discovered to reflect a general principle
of Wnt signaling during brain development, in which an
anteroposterior gradient (low Wnt signaling for anterior
structures, high for posterior structures) is important for
proper regional specification (Machon et al. 2007; Hoch et
al. 2009; Patapoutian and Reichardt 2000). Wnt/β-catenin
signaling is critical for specification of the hippocampus
(Galercan et al. 2000; Lee et al. 2000) and for proliferation
of neuronal precursors (Zhou et al. 2006), as well as for
directing the radial migration of neurons into the cortex
(Zhou et al. 2004). The roles that Wnt/β-catenin signaling
plays in these neurodevelopmental processes and their
potential and real implications for neurodevelopmental
and/or psychiatric disorders are the subject of much
investigation and have already been widely discussed in
the scientific literature (Freese et al. 2010; De Ferrari and
Moon 2006; Toro and Deakin 2006; Li et al. 2005; Mao et
al. 2009) and will therefore not be a further focus of this
review.
Wnt/PCP signaling is also tremendously important for
nervous system development in vertebrates (Tissir and
Goffinet 2010). The importance of PCP signaling is most
notable in the process of convergent extension that
produces the notochord and, eventually, the spine. During
morphogenesis of these structures, cells must converge
from the sides of the organism to the midline, and
disruption of PCP signaling leads to a failure in this
process. One common and clinically relevant consequence
of disruptions in PCP signaling is failure of neural tube
closure. In mild cases, the neural tube fails to close only at
the lower end of the spinal cord producing spina bifida; in
severe cases, the whole spine and even the skull may fail to
close leaving the spinal cord and brain exposed, a lethal
condition known as craniorachischisis. The family of Dvl
proteins and the four-pass transmembrane protein Van
Gogh-like 2 (Vangl2) are core components of the PCP
signaling pathway; knockout of the Dvl genes causes
craniorachischisis (Etheridge et al. 2008), as does the
Looptail (Lp) allele of Vangl2 in mice homozygous for
the mutation (Strong and Hollander 1947; Kibar et al. 2001).
The molecular basis for these phenotypes downstream of the
Vangl and Dvl proteins is complex but involves the family of
Rho small GTPases and their regulation of actin dynamics
and cytoskeletal organization. For example, Dvl1 has been
shown to bind Rac directly and promote its activity (Rosso et
al. 2005). Vangl2 can bind and redistribute Rac to adherens
junctions, while disruption of Vangl2 signaling results in loss
of Rho activity in the mouse Lp mutant (Phillips et al. 2009).
Wnts and axon guidance
Wnt signaling is important for axon development and guidance
(Bovolenta et al. 2006;Z o u2004). Generally, Wnt–Fzd
signaling has been found to mediate attractive cues (Lyuksyu-
tova et al. 2003;W a n ge ta l .2006a) whereas Wnt–Ryk
signaling mediates repulsive cues (Keeble et al. 2006; Liu et al.
2005) to extending axons. Specifically, Wnt4–Fzd3 signaling
directs axonal projection of spinal cord neurons after crossing
the midline (Lyuksyutova et al. 2003), while a Wnt5a–Ryk
interaction helps direct axons routed through the corpus
callosum (Keeble et al. 2006) and corticospinal tract (Liu et
al. 2005). Interestingly, the relevant Wnt–Fzd pathway seems
to involve β-catenin, but not the entire canonical Wnt pathway
in which β-catenin drives gene transcription (Zou 2004).
In addition to providing guidance cues, Wnt signaling
regulates cytoskeletal dynamics in the growth cone and during
axon branching. Wnt7a has been shown to control growth cone
spreading and axon branching in the cerebellum (Lucas and
Salinas 1997;H a l le ta l .2000), as does Wnt3a in spinal cord
neurons (Krylova et al. 2002; Purro et al. 2008). It was also
found that the effect of Wnt7a on axons could be mimicked by
inhibition of GSK3β, suggesting that a downstream
microtubule-regulating pathway is mediated by GSK3β
activity (Lucas and Salinas 1997;H a l le ta l .2000). Dvl1 is
involved in this process, as shown by deficits in microtubule
dynamics in Dvl1 knockout animals (Purro et al. 2008).
Concordantly, a recent study identified complementary cell
biological roles for Dvl1 and Vangl2 in regulating Fzd3
signaling downstream of Wnt5a during commissural growth
cone guidance (Shafer et al. 2011).
Wnts and dendrite formation
Less is presently known about the role of Wnt signaling in
dendrite development. Studies in cultured hippocampal neurons
(HCNs) have shown that an increase in Wnt7b (Rosso et al.
2005) or in Wnt2 are both associated with increases in
complexity of dendritic arbors and that Wnt2 transcription is
upregulated by neuronal activity in this system (Wayman et al.
2006). The Ror tyrosine kinases promote dendrite branching
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through Rac and JNK (Rosso et al. 2005), as well as through a
β-catenin-dependent (but non-canonical) pathway (Yu and
Malenka 2003). It should be noted that, as with the β-catenin
pathway involved in axon remodeling, the β-catenin-mediated
response reported in this study is not due to LEF/TCF
transcription and seems to rely instead on regulation of cell
adhesion through β-catenin’s interaction with adhesion mole-
cules such as the cadherins.
Wnt signaling and the synapse
Wnt signaling is also implicated in synapse formation and
maintenance. The first evidence that Wnt signaling con-
tributes to synapse development came from a study
implicating Wnt7a in axon extension and in clustering of
presynaptic proteins in cerebellar granule neurons (Lucas
and Salinas 1997). Wnt signaling has also been implicated
in synapse formation at the neuromuscular junction (NMJ)
in fruit flies (Wu et al. 2010) and in Caenorhabditis elegans
(Davis and Ghosh 2007) and in the hippocampus and
cerebellum of the mammalian CNS (Farias et al. 2010;
Speese and Budnik 2007; Tang 2007).
Wnt signaling at the NMJ
Wg (the Drosophila homolog of Wnt1) has both pre- and
postsynaptic effects at the Drosophila NMJ, where Wg is
released in conjunction with neuronal activity. During
anterograde signaling, Wg made in the presynaptic motor
neuron travels across the synaptic cleft in association with
lipid and a transmembrane protein called evenness inter-
rupted (Korkut et al. 2009). It then binds to the Fzd2
receptor expressed by postsynaptic muscle cells, leading to
internalization and cleavage of Fzd2, with the intracellular
domain of the receptor transported into the muscle nucleus
where it may directly regulate transcription (Mathew et al.
2005). Wg release also causes changes in the motor neuron
itself in an autocrine manner by binding to presynaptic
Fzd2. The machinery downstream of this includes Dvl and
GSK3-mediated phosphorylation of microtubule associated
proteins, with the net effect being stabilization of micro-
tubules and increases in local axonal complexity (Ciani and
Salinas 2007). A molecularly similar signal transduction
mechanism may contribute to increases in presynaptic
transmitter release and to synaptic potentiation upon
repeated depolarization (Ataman et al. 2008).
In contrast, the Wnt lin-44 in C. elegans is a non-
permissive signal for synapse formation in the posterior of
the worm; null mutation of lin-44 or its receptor lin-17, a
Fzd receptor, causes expansion of synapse formation into a
region where that neuron’s synapses do not normally form,
as does removal of dsh-1, the C. elegans Disheveled gene
(Klassen and Shen 2007). Evidence therefore suggests that
Wnts can provide either positive or negative signals for
synapse formation at the NMJ, depending on the organism
and cellular context.
Wnts and synapse formation in the mammalian CNS
The hippocampus has been intensely studied as a model for
synapse formation in mammalian forebrain neurons be-
cause of its stereotyped anatomy and the relative ease of
obtaining adequately pure populations of hippocampal
pyramidal neurons for culture, in addition to its behavioral
relevance in memory formation (Banker and Goslin 1998).
Wnt3, Wnt5a, Wnt7a, and Wnt7b are all present in the
mammalian hippocampus, although Wnt3 is not widely
expressed (Rosso et al. 2005; Davis et al. 2008). The Wnt
receptors Fzd3, Fzd5, Fzd8, and Fzd9 are also all expressed
in the postnatal hippocampus (Davis et al. 2008;Z h o ue ta l .
2010). These Wnts and Fzds are therefore natural candidates
for considering the role of Wnt signaling at mammalian CNS
synapses.
Current understanding of the role of the “canonical”
Wnts—those associated with Wnt/β-catenin signaling—in
synapse formation is straightforward. Available evidence
concurs that Wnt3a, Wnt7a, and Wnt7b raise nuclear levels
of β-catenin and promote organization of presynaptic sites
in the cerebellum (Lucas and Salinas 1997; Ahmad-Annuar
et al. 2006) as well as in HCNs (Davis et al. 2008).
Wnt signaling through Wnt7a/7b in mice has also been
shown to be increased by exposure to a stimuli-enriched
environment, with a corresponding increase in synaptic
terminal complexity in CA3 hippocampal neurons receiving
input frommossy fiber axons fromthe dentate gyrus (Gogolla
et al. 2009). These changes, however, seem to be through
some mechanism other than the full canonical Wnt/β-catenin
signaling pathway because their signaling outcome, as far as
is presently known, is not β-catenin-mediated transcriptional
regulation. They have instead been linked to changes in
microtubule organization (Hall et al. 2000), APC-mediated
protein clustering (Farias et al. 2007), and β-catenin
mediated cell–cell adhesion (Bamji et al. 2003), the last of
which has not been shown to be triggered by Wnt/Fzd/Dvl
signaling at all.
In contrast, there is contradictory evidence for the role of
Wnt/PCP signaling mediated by Wnt5a in synapse forma-
tion. One study found that Wnt3, Wnt7a, or Wnt7b
application all increased the number of presynaptic protein
clusters in Wnt-treated neurons, whereas application of
Wnt5a did not increase nuclear β-catenin and decreased the
number of presynaptic protein clusters. Based on this and
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signaling is positive and Wnt/PCP signaling negative for
synapse formation (Davis et al. 2008). In striking
contrast, a set of studies from another group has found
that application of Wnt5a increased clustering of both
excitatory and inhibitory postsynaptic proteins through
calcium and JNK-mediated pathways while not affecting
presynaptic sites; the authors therefore concluded that
Wnt/Ca
2+ and Wnt/PCP signaling promote synapse for-
mation (Farias et al. 2009; Varela-Nallar et al. 2010;
Cuitino et al. 2010). Another study found that transfection
of astrocytes with Wnt5a led to an increase in presynaptic
puncta in co-cultured HCNs and that this increase was
dependent on the non-canonical Wnt receptor Ror (Paganoni
et al. 2010). The three sets of observations are not necessarily
irreconcilable, as the experimental methods of each study
vary at several points. If all published observations are
correct, Wnt signaling through Wnt5a can either promote
or inhibit synapse formation in vivo, depending on local
conditions, and does so through both the Wnt/Ca
2+ and
Wnt/PCP pathways. Known connections between Wnt
signaling and synapse formation in vertebrates are sum-
marized in Fig. 2.
Wnt signaling transducers and synapse formation
Some key downstream components of Wnt signaling
pathways have also been strongly implicated in synapse
formation. For example, Fzd proteins have been linked to
Fig. 2 Wnts exert both pre- and post-synaptic effects. Presynaptic
Wnt signaling through Wnt3 and Wnt7 acts through a Dvl pathway to
stabilize microtubules and also influences presynaptic clustering of
acetylcholine receptors (AChRs) through an APC-mediated mecha-
nism (upper left). Presynaptic β-catenin is also involved in synapse
formation and maintenance through cell–cell adhesion mechanisms,
though a relationship between this and Wnt signaling remains
speculative. Wnt5a-activated signaling through the Ror kinase is also
thought to contribute to an increase in presynaptic sites through a
mechanism that has not yet been determined (upper right). Postsyn-
aptic Wnt signaling driven by Wnt5a probably acts through a Dvl/Rac/
JNK pathway to regulate the actin cytoskeleton (lower right).
Application of Wnt3a, Wnt 7a, or Wnt7b is sufficient to induce β-
catenin translocation to the nucleus and may well also influence
synapses (not shown). As in the presynaptic terminal, β-catenin is
present in the postsynaptic density of excitatory synapses where it is
involved in cell–cell adhesion. Also not shown is a highly divergent
postsynaptic pathway established at the Drosophila neuromuscular
junction involving cleavage and translocation of Fzd receptors to the
nucleus; there is evidence that a mechanistically similar pathway
operates at some vertebrate synapses
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Dact1synapse formation in two quite disparate ways. First, Fzd2
has been shown to regulate postsynaptic transcription at the
NMJ through a mechanism involving cleavage of Fzd2 and
transport of a fraction of the cleaved protein to the nucleus
(Mathew et al. 2005;M o s c aa n dS c h w a r z2010). Second,
Fzd1 has been found to mediate Wnt3a signaling (Varela-
Nallar et al. 2009) and Fzd5 to mediate Wnt7a signaling
(Sahores et al. 2010) leading to increased synapse formation,
in particular the organization of new presynaptic terminals,
in cultured hippocampal neurons.
In Drosophila, the arrow Wg receptor that is homolo-
gous to mammalian LRP5/6 has also been implicated in
synapse formation at the NMJ through a presynaptic
pathway involving Wg, dsh, and shaggy/GSK3, but which
is linked to regulation of microtubule dynamics rather than
to β-catenin-dependent transcriptional regulation (Miech et
al. 2008).
Several scaffold proteins associated with Wnt signaling,
including APC, axin, Dvl1, and the Dvl-binding Wnt
signaling modulator Dact1, have all been shown to function
at the synapse as well. APC participates in Wnt-induced
presynaptic clustering of nAChR receptors (Farias et al.
2007); axin localizes to the synapse and binds the synaptic
scaffold molecule S-SCAM (Hirabayashi et al. 2004). Loss
of the key Wnt signaling transductor Dvl1 has been shown
to produce a loss of presynaptic sites in the cerebellum
(Ahmad-Annuar et al. 2006) and a reduction in dendrite
complexity in hippocampal neurons (Rosso et al. 2005).
Loss of Dact1 has also been shown to result in a loss of
dendrite complexity, as well as a loss of dendritic spines
and excitatory (but not inhibitory) synapses in hippocampal
neuron culture, a deficit traced to decreases in active Rac
(Okerlund et al. 2010).
β-Catenin has been linked to synapse formation through
a role in the clustering of presynaptic proteins (Bamji et al.
2003; Lee et al. 2008; Sun et al. 2009) and through
regulation of cadherin-mediated adhesion (Arikkath and
Reichardt 2008; Uchida et al. 1996; Benson and Tanaka
1998). It has also been shown to mediate transcription
postsynaptically after NMDA receptor activation (Abe and
Takeichi 2007). However, reduction of β-catenin levels in
postnatal forebrain leads to only subtle behavioral changes
in mice (Gould et al. 2008).
Wnts and the neurodevelopmental hypothesis
of psychiatric disorders
Since Wnt signaling is important in organizing the
developing brain, it is plausible that defects in Wnt
signaling contribute to illnesses such as autism, bipolar
disorder, and schizophrenia. Although our understanding of
the biological basis for these psychiatric disorders remains
limited, contemporary models for their pathophysiology
generally posit neurodevelopmental origins (Harrison and
Weinberger 2005; Bourgeron 2009; Guilmatre et al. 2009;
Sutcliffe 2008). Accumulating evidence suggests that
improper formation or regulation of synapses is an
important contributor to these neurodevelopmental dis-
eases, especially since they are associated with only mild
gross anatomical defects (Guilmatre et al. 2009; Newey et
al. 2004; von Bohlen und Halbach 2009; Penzes et al.
2011). In addition, numerous proteins contributing to Wnt
signaling have been implicated in the etiology of these
disorders through genetic, biochemical, and pharmacolog-
ical analyses (De Ferrari and Moon 2006; Hur and Zhou
2010; Gould and Manji 2002; Kozlovsky et al. 2002).
Wnt signaling and schizophrenia
Schizophrenia is a psychiatric disorder characterized by
“positive” symptoms such as delusions, hallucinations, and
disorganized speech and “negative” symptoms such as lack
of emotional affect and motivation (American Psychiatric
Association 2000). Neuroanatomical defects associated
with schizophrenia are subtle but include enlargement of
the lateral ventricles (Steen et al. 2006), disorganization of
forebrain structures (Harrison 1999), loss of neuropil, and
fewer synapses in pyramidal neurons (Harrison and
Weinberger 2005; Hill et al. 2006; Ross et al. 2006;
Jarskog et al. 2007). The neurodevelopmental hypothesis of
schizophrenia posits that such defects are caused by
dysregulation of brain development (Harrison and Wein-
berger 2005; Guilmatre et al. 2009; Ross et al. 2006;
Jarskog et al. 2007; Cantor and Geschwind 2008), and the
Wnt signaling pathway is a candidate for such a
dysregulated system. Since, as discussed above, Wnt
signaling is important for brain regionalization, develop-
ment of the hippocampus, neuronal proliferation, neuronal
migration, and synapse formation, dysregulation of Wnt
signaling could simultaneously produce a reduction in
hippocampal volume, disorganization of forebrain struc-
tures (through incorrect specification, proliferation, and/or
migration), and synaptic defects such as those seen in
schizophrenia.
Schizophrenia has a strong genetic component (Sullivan
et al. 2003). Although no Wnt ligands have been identified
as genes of interest in genome-wide association studies
(GWAS) or other linkage studies, Wnt1 has been reported
to be upregulated in schizophrenic brains (Miyaoka et al.
1999), and some genes associated with susceptibility to the
disease are core components of the Wnt signaling pathway.
Perhaps most striking is a recent finding that the Wnt/β-
catenin-activated transcription factor TCF4 is one of only
three genes with a single nucleotide polymorphism (SNP)
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the whole genome (Stefansson et al. 2009). The other genes
identified in the study were in the major histocompatibility
complex and neuregulin, a protein involved in neuronal
migration and synaptic function which had previously been
strongly linked to the genetics of schizophrenia (Buonanno
2010). TCF4 itself has been shown to have a role in brain
development (Broźozka et al. 2010; Kunz et al. 2004; Cho
and Dressler 1998), and TCF4 haploinsufficiency causes
Pitt–Hopkins syndrome, which includes severe mental
retardation as one of its features (Brockschmidt et al.
2007; de Pontual et al. 2009). TCF4 overexpression in the
brain has also been reported to cause memory deficits and,
importantly, deficits in prepulse inhibition, a neurophysio-
logical correlate of schizophrenia and other psychiatric
disorders (Broźozka et al. 2010).
Dkk proteins—extracellular proteins that compete with
Wnts for binding to LRP5/6 receptors and thereby disrupt
the Fzd-LRP5/6 complex that initiates Wnt/β-catenin
signaling—have also been implicated in schizophrenia via
several genetic screens. Dkk1, Dkk3, and Dkk4 have all
been identified as genes of interest in genome analyses of
mutations associated with schizophrenia (Aleksic et al.
2010; Proitsi et al. 2008; Ftouh et al. 2005), as has the
Dkk1 co-receptor KREMEN1 (Aleksic et al. 2010).
Intriguingly, the human Dkk1 homolog was first isolated
via interaction with neuregulin (Fedi et al. 1999).
The role of the Dkk family members in brain develop-
ment is still relatively undefined. Dkk1 is expressed only at
very low levels in the healthy brain but is upregulated in
response to neurodegeneration (Caraci et al. 2008). Dkk3 is
t h em o s ts t r o n g l ya n dw i d e l ye x p r e s s e dD k kf a m i l y
member in the brain during development (Diep et al.
2004) and is upregulated in Alzheimer’s patients, possibly
also as a response to neurodegeneration (Zenzmaier et al.
2009); female Dkk3 knockout mice were also observed to
be slightly hyperactive (Barrantes et al. 2006). Dkk4 is not
known to be strongly expressed in the brain at any time, but
it is upregulated in some brain regions in response to
elevated β-catenin levels during development (Diep et al.
2004). No specifically synaptic role for any of these three
Dkk proteins has been identified, although application of
exogenous Dkk1 has been found to reduce clustering of
presynaptic proteins in hippocampal neuronal culture
(Davis et al. 2008).
GSK3 is another key regulator of Wnt signaling with
genetic and pharmacological ties to schizophrenia. Poly-
morphisms in the GSK3β locus have been linked to
susceptibility for schizophrenia (Scassellati et al. 2004;
Souza et al. 2008), and as described in the first section,
regulation of GSK3β activity is central to the Wnt/β-catenin
signaling pathway (Wu and Pan 2010). However, it is worth
emphasizing that GSK3β, along with many other compo-
nents of the Wnt signal transduction machinery, also plays
prominent roles in several biochemical and signaling path-
ways independent of Wnts (Hur and Zhou 2010; Cohen and
Frame 2001; Jope and Roh 2006). Therefore, an important
general caveat in considering such evidence is that some of
these non-Wnt related biochemical roles—not only for
GSK3β but also for the other Wnt signaling components
mentioned—may in the end be more relevant to psychiatric
pathogenesis.
Other genes linked to schizophrenia that can also
modulate Wnt signaling include Disrupted In SChizophrenia
1 (DISC1), a scaffold protein whose genetic locus is
mutated in affected members of a family with a high
incidence of schizophrenia (Millar et al. 2000). DISC1
helps regulate neuronal migration and synapse formation
(Hayashi-Takagi et al. 2010; Singh et al. 2010) and has
b e e nl i n k e dt oW n t / β-catenin signaling both through
interaction with GSK3β (Mao et al. 2009) as well as with
the scaffold protein DIX Domain Containing 1 (DIXDC1)
(Singh et al. 2010).
Also suggestive is that human chromosomal region 8p,
genetically implicated in neuropsychiatric and other dis-
eases (Harrison and Weinberger 2005; Tabares-Seisdedos
and Rubenstein 2009), contains at least three Wnt-
signaling-related genes (FZD3, DKK4, and SFRP1). FZD3
in particular has been put forward as a potential schizo-
phrenia susceptibility locus (Katsu et al. 2003; Yang et al.
2003; Zhang et al. 2004), although successive genetic
linkage studies have cast doubt on initial findings linking
mutations in the gene to schizophrenia incidence in the
general population (Ide et al. 2004; Wei and Hemmings
2004). Importantly, Fzd3 has roles in axon guidance
(Lyuksyutova et al. 2003; Wang et al. 2006a; Shafer et al.
2011) and PCP signaling (Wang et al. 2006b; Shafer et al.
2011). The roles of Dkk4 (discussed above) and Sfrp1 in
brain development have received relatively little analysis,
but deletion of Sfrp1 has been shown to have no obvious
effect on gross anatomy of the nervous system in mice
(Trevant et al. 2008).
In addition to these genetic and other connections,
antipsychotics such as haloperidol and clozapine have been
reported to increase protein levels of β-catenin, GSK3β,a n d
Dvl3 in the brains of adult rats, whereas amphetamine, which
can induce psychosis, has the opposite effect (Alimohamad et
al. 2005). Haloperidol has also been reported to reduce
phospho-GSK3β (Kozlovsky et al. 2006), providing another
biochemical link between GSK3 activity and schizophrenia
pharmacotherapeutics. Interestingly, changes in Wnt signal-
ing induced by antipsychotic administration in a cellular
assay can be mimicked by overexpression of Dvl3 (Sutton et
al. 2007). Taken together, the genetic and pharmacological
data suggest a potential connection between Wnt signaling
and the pathogenesis and therapeutics of schizophrenia.
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Autism is a childhood-onset psychiatric disorder character-
ized by impairment of social interaction, difficulty in
communication, and perseverative stereotyped behaviors
(American Psychiatric Association 2000). As with schizo-
phrenia, a defect in synapse formation is a leading current
hypothesis for its pathogenesis (Bourgeron 2009; Guilmatre
et al. 2009; Sutcliffe 2008). The genes currently most
tightly linked to autism causality, although only accounting
in themselves for a small percentage of cases, include the
neuroligin family of adhesion proteins and associated
molecules which are important for synapse formation and
maintenance (Bourgeron 2009; Guilmatre et al. 2009;
Sutcliffe 2008; Südhof 2008; Chubykin et al. 2005).
Autism is also associated with macrocephaly in early stages
of development (McCaffery and Deutsch 2005), an in-
creased number of neurons in the brain (Casanova et al.
2006), and misplaced or misoriented neurons due to
incorrect neuronal migration, especially for Purkinje neu-
rons (Wegiel et al. 2010; Palmen et al. 2004). Since Wnt
signaling is an important factor in proliferation, cell fate
specification, migration, and synaptogenesis, a defect in
Wnt signaling could produce all of these defects, and it is
reasonable to look for connections between deficits in Wnt
signaling and autism.
There is some evidence for a direct genetic link between
Wnt2 and autism spectrum disorders in rare cases. Two
studies have found a correlation between mutation of the
WNT2 locus and the incidence of autism in different
populations (Marui et al. 2010; Wassink et al. 2001),
although this finding has not been replicated by other
studies (McCoy et al. 2002;L ie ta l .2004). Wnt2 has also
been found to be expressed at lower levels in a mouse
model of fragile X syndrome than in wild-type mice (Zhang
et al. 2009), and while typified by mental retardation, a
significant fraction of patients with fragile X syndrome also
have autistic symptoms.
No similar genetic links have yet been found with
Wnt receptors, but Wnt signaling has also been related to
autism through downstream signaling components and
transcriptional targets. For example, Dvl1 knockout mice
show behavioral impairments of potential relevance to
autism, including loss of sociability (decreased huddling)
and abnormal social interactions (reduced barbering of
facial whiskers; Lijam et al. 1997); this is especially
notable in light of the effects of Dvl1 knockout on
synapses (Rosso et al. 2005; Ahmad-Annuar et al. 2006).
Wnt signaling is also linked to autism through TSC1 and
2, scaffold proteins that are mutated in tuberous sclerosis
(a developmental disorder that, like fragile X syndrome,
often includes features of autism; Wiznitzer 2004). TSC1
and 2 regulate Wnt/β-catenin signaling through interaction
with GSK3 and axin (Mak et al. 2003). The transcription
factor Engrailed 2 (En2), a Wnt/β-catenin transcriptional
target (Kuemerle et al. 2007), has been genetically linked
to autism both through human genetics showing associa-
tion of SNPs with the disease (Benayed et al. 2009;Y a n g
et al. 2010; Sen et al. 2010) and through a mouse model
showing that En2 knockout produces cerebellar patterning
deficits similar to those seen in autism, as well as social
behavioral deficits (Kuemerle et al. 2007;C h e he ta l .
2006). Finally, fragile X mental retardation protein
(FMRP), an RNA-binding protein strongly associated with
autistic-like symptoms and mental retardation when
mutated (Pfeiffer and Huber 2009; Bassell and Warren
2008) ,h a sr e c e n t l yb e e ns h o w nt op l a yar o l ei nW n t
signaling in a FMRP knockout mouse (Luo et al. 2010),
offering another potential connection between Wnt signaling
and autism. Interestingly, some, but not all, of the autism-
relevantbehavioralphenotypesobservedinaFMR1 knockout
mouse are also observed in a mouse model in which GSK3
is constitutively active (Mines et al. 2010).
Wnt signaling and bipolar disorder
Bipolar disorder, another psychiatric disorder potentially
linked to changes in neural plasticity (Schloesser et al.
2008) and synapse formation (Eastwood and Harrison
2009), is characterized by phases of mania, in which the
subject feels an abnormal surge of energy and heightened
mood, sometimes leading to delusions and even psychosis,
alternating with phases of depression, with accompanying
loss of energy and negative mood (American Psychiatric
Association 2000). Based on GWAS and linkage studies,
there is no demonstrated genetic association between the
genetics of bipolar disorder and genes for either the Wnt
ligands themselves or any of their known receptors.
However, as with schizophrenia, Wnt signaling is implicat-
ed in the pathogenesis and therapeutics of bipolar disorder,
with the pharmacological link between Wnt/β-catenin
signaling, GSK3 activity, and lithium being fairlyprovocative
(Gould and Manji 2002).
Lithium has been used to treat bipolar disorder for
decades and is still the most widely used treatment for the
disorder (Hirschowitz et al. 2010). Among its other effects,
including inhibition of inositol phosphatases (Beaulieu and
Caron 2008; Quiroz et al. 2004), lithium inhibits GSK3 and
promotes β-catenin-mediated transcriptional activation at
therapeutic doses (Hedgepeth et al. 1997; Klein and Melton
1996). Intriguingly, mice missing one copy of GSK3β
show reduced immobility in the forced swim test, a
behavioral measure of antidepressant effects, as do mice
dosed with lithium at therapeutic concentrations (O’Brien et
al. 2004). GSK3β and Wnt/β-catenin signaling have
J Neurodevelop Disord (2011) 3:162–174 169therefore been of interest in bipolar disorder, and human
genetics has revealed that copy number variation in the 3′
non-coding region of the GSK3β locus is more frequent in
bipolar patients than in controls (Lachman et al. 2007). In a
meta-analysis of all candidates, the GSK3β locus was found
to be implicated in bipolar disorder by the widest array of
studies, including association analysis, gene expression,
pharmacogenomics, structural variants, and mouse models
(Luykx et al. 2009).
The simplest pharmaceutical model based on these
findings would be one in which administration of lithium
corrects an underlying GSK3 hyperactivity associated with
bipolar pathogenesis. Since in the absence of a Wnt ligand
GSK3 activity promotes β-catenin degradation and inhibits
the pathway, one might predict that there should be
abnormal downregulation of β-catenin-mediated transcrip-
tional targets in untreated bipolar patients. Paradoxically,
available evidence suggests instead that there is an
upregulation of β-catenin transcriptional targets in bipolar
patients (Matigian et al. 2007; Zandi et al. 2008). In this
regard, it is important that GSK3 operates as a switch;
while inhibiting the pathway in the absence of a signal, it
also participates in Wnt/β-catenin signal pathway activation
by phosphorylating the LRP5/6 receptor (Zeng et al. 2005)
and transcriptional co-activators (Scassellati et al. 2004)i n
the presence of a signal. These signal-promoting activities
of GSK3 might therefore be more relevant to the
pathophysiology of bipolar disorder.
Wnt signaling in psychiatry: “to β or not to β”
Although β-catenin-dependent and β-catenin-independent
Wnt signaling are both implicated in neural development,
studies of Wnt signaling in disease have historically
centered mostly on the canonical Wnt/β-catenin signaling
pathway, the first described and molecularly best-
understood Wnt pathway, whereas other types of Wnt
signaling have generally been less thoroughly interrogated
for connections to disease in general and to mental illness
in particular. Given structural alterations found in major
psychiatric disorders including modest changes in the sizes,
shapes, cellular architecture, and differential growth char-
acteristics of some brain regions, it remains reasonable to
explore potential contributions of Wnt/β-catenin signaling
to psychiatric pathogenesis. Simultaneously, given the
importance of cytoskeletal regulation and calcium release
in synapse formation and function (Luo 2002; Koh 2006;
Nakayama et al. 2000), potential connections between Rho
GTPases and mental illness (Newey et al. 2004), the
sensitivity of Wnt/PCP signaling to dosage effects includ-
ing those caused by genetic perturbations in mammalian
animal models (Etheridge et al. 2008; Wang et al. 2006c;
Suriben et al. 2009), and evidence that signal transduction
mechanisms at synapses downstream of Wnts are highly
divergent from previously described pathways, it may be
that Wnt/PCP, Wnt/Ca
++, and other “non-canonical” forms
of Wnt signaling are as important or more important than
Wnt/β-catenin signaling in the pathogenesis of psychiatric
disorders. These pathways therefore deserve further scruti-
ny in studies of neural differentiation, synapse maintenance,
synaptic plasticity, and their consequences for complex
behavior and the etiology of major mental illnesses.
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